Science & technology | Covid-19 vaccines

With millions vaccinated, rare side-effects of jabs are emerging

Johnson & Johnson’s vaccine is the latest to suffer a setback

CHRIS WHITTY, England’s chief medical officer, vividly recalls a nerve-racking moment on December 8th 2020. That was the day when England became the first country to roll out a covid-19 vaccine, a jab developed by Pfizer and BioNTech. Near midnight on vaccination day one “We were discussing it and just thinking ‘What are we dealing with here? These are small numbers and we’ve already had several dangerous near misses’,” said Dr Whitty in a recent talk at the Royal Society of Medicine. In some people, it had turned out, the vaccine sets off anaphylaxis, a life-threatening allergic reaction. But this is rare. It occurred just once among the 22,000 or so people vaccinated in the trial, which could have been by chance. Now, with hundreds of millions vaccinated, the rate at which it occurs is clearer: five per million.

This article appeared in the Science & technology section of the print edition under the headline “Sorting signal from noise”

Riding high: A special report on the future of work

From the April 10th 2021 edition

Discover stories from this section and more in the list of contents

Explore the edition

More from Science & technology

Parasitic wasp - laying egg in hoverfly larvae.

Wasps stole genes from viruses

That probably assisted their evolutionary diversification

The World Health Organisation crest on the wall.

America’s departure from the WHO would harm everyone

Whether it is a negotiating ploy remains to be seen



High-tech antidotes for snake bites

Genetic engineering and AI are powering the search for antivenins

Can you breathe stress away?

Scientists are only beginning to understand the links between the breath and the mind

The Economist’s science and technology internship

We invite applications for the 2025 Richard Casement internship